These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 623674

  • 1. Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine.
    Fuller RW, Snoddy HD, Perry KW, Bymaster FP, Wong DT.
    Biochem Pharmacol; 1978 Jan 15; 27(2):193-8. PubMed ID: 623674
    [No Abstract] [Full Text] [Related]

  • 2. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.
    Fuller RW, Perry KW, Molloy BB.
    J Pharmacol Exp Ther; 1975 Jun 15; 193(3):793-803. PubMed ID: 1151729
    [Abstract] [Full Text] [Related]

  • 3. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT, Bymaster FP.
    Res Commun Chem Pathol Pharmacol; 1976 Oct 15; 15(2):221-31. PubMed ID: 981783
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake.
    Ross SB.
    Acta Pharmacol Toxicol (Copenh); 1976 Oct 15; 39(4):456-76. PubMed ID: 989691
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice.
    Fuller RW, Perry KW, Snoddy HD, Molloy BB.
    Eur J Pharmacol; 1974 Sep 15; 28(1):233-6. PubMed ID: 4430328
    [No Abstract] [Full Text] [Related]

  • 6. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats.
    Fuller RW, Snoddy HD.
    Pharmacol Biochem Behav; 1986 Feb 15; 24(2):281-4. PubMed ID: 3485293
    [Abstract] [Full Text] [Related]

  • 7. Reversible and irreversible effects of p-chloroamphetamine on brain serotonin in mice.
    Steranka L, Bessent R, Sanders-Bush E.
    Commun Psychopharmacol; 1977 Feb 15; 1(5):447-54. PubMed ID: 606480
    [No Abstract] [Full Text] [Related]

  • 8. Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine.
    Fuller RW, Perry KW, Molloy BB.
    Eur J Pharmacol; 1975 Aug 15; 33(1):119-24. PubMed ID: 126166
    [Abstract] [Full Text] [Related]

  • 9. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors.
    Fuller RW, Snoddy HD, Molloy BB.
    Psychopharmacol Commun; 1975 Aug 15; 1(5):455-64. PubMed ID: 1228825
    [Abstract] [Full Text] [Related]

  • 10. Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain.
    Fuller RW, Perry KW.
    Neuropharmacology; 1977 Aug 15; 16(7-8):495-7. PubMed ID: 917253
    [No Abstract] [Full Text] [Related]

  • 11. Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.
    Mishra R, Sulser F.
    Commun Psychopharmacol; 1978 Aug 15; 2(4):365-9. PubMed ID: 310378
    [No Abstract] [Full Text] [Related]

  • 12. Cyproheptadine antagonism of p-chloroamphetamine hypothermia in mice.
    Burke DH, Ryan RP.
    Eur J Pharmacol; 1986 Sep 23; 129(1-2):195-8. PubMed ID: 2429848
    [Abstract] [Full Text] [Related]

  • 13. Blockade of para-methoxyamphetamine- induced serotonergic effects by chlorimipramine.
    Tseng LF, Harris RA, Loh NH.
    J Pharmacol Exp Ther; 1978 Jan 23; 204(1):27-38. PubMed ID: 579354
    [No Abstract] [Full Text] [Related]

  • 14. Inability of an inhibitor of amine uptake (Lilly 110140) to block depletion of brain 5-hydroxytrptamine by L-dopa.
    Fuller RW, Perry KW.
    J Pharm Pharmacol; 1975 Aug 23; 27(8):618-20. PubMed ID: 239182
    [No Abstract] [Full Text] [Related]

  • 15. Antagonism by (--)-methadone of the depletion of 5-hydroxytryptamine in rat brain by p-chloroamphetamine.
    Fuller RW, Perry KW, Hynes MD.
    J Pharm Pharmacol; 1981 Jan 23; 33(1):48-9. PubMed ID: 6114155
    [No Abstract] [Full Text] [Related]

  • 16. Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine.
    Gershon MD, Jonakait GM.
    Br J Pharmacol; 1979 May 23; 66(1):7-9. PubMed ID: 313230
    [Abstract] [Full Text] [Related]

  • 17. Effects of 4-(3-indolyl-alkyl) piperidine derivatives on brain 5-hydroxytryptamine turnover and on cardiac and brain noradrenaline or 5-hydroxytryptamine depletion induced by 6-hydroxydopamine, H 75/12 and 4-chloroamphetamine.
    Le Fur G, Mitrani N, Uzan A.
    Biochem Pharmacol; 1977 Mar 15; 26(6):505-9. PubMed ID: 849347
    [No Abstract] [Full Text] [Related]

  • 18. On the selective inhibition of serotonin uptake in vivo by Org 6582.
    Sugrue MF, Goodlet I, Mireylees SE.
    Eur J Pharmacol; 1976 Nov 15; 40(1):121-30. PubMed ID: 991921
    [Abstract] [Full Text] [Related]

  • 19. Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats.
    Fuller RW, Snoddy HD.
    Res Commun Chem Pathol Pharmacol; 1978 Sep 15; 21(3):457-65. PubMed ID: 705024
    [Abstract] [Full Text] [Related]

  • 20. Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitors.
    Fuller RW, Perry KW.
    J Pharm Pharmacol; 1977 Nov 15; 29(11):710-1. PubMed ID: 22613
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.